• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Theravance Bio Reports Q3 2024 Results & Shareholder Initiatives

    PR NEWSWIRE

    Theravance Publishes YUPELRI® Spirometry Analysis In Journal

    PR NEWSWIRE

    Theravance Biopharma Reports Q2 2024 Results And Business Update

    PR NEWSWIRE

    Theravance Biopharma to Participate in an Upcoming Investor Conference

    PR NEWSWIRE

    Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI

    PR NEWSWIRE

    FDA Confirms Paragraph IV Patent Litigation for Revefenacin Inhalation Solution

    FDA

    Theravance Biopharma, Inc. Initiates $250 Million Capital Return Program

    PRNEWSWIRE

    Theravance Biopharma and Mylan Expand YUPELRI® Dev. & Commercialization

    PR NEWSWIRE

    Theravance Biopharma & Mylan Present Additional YUPELRI® Phase 3

    PR NEWSWIRE

    Theravance Biopharma & Mylan FDA Approval for YUPELRI™ (revefenacin) inCOPD

    PR NEWSWIRE

    Mylan and Theravance`s COPD treatment gets FDA approval

    REUTERS

    Theravance Biopharma and Mylan Report +ve New Data of Studies of YUPELRI

    PR NEWSWIRE

    Theravance Biopharma and Mylan Report +ve New Data of Studies of YUPELRI

    PR NEWSWIRE

    Theravance Biopharma and Mylan Report +ve New Data of Studies of YUPELRI

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.